Epidemiology of chronic obstructive pulmonary disease: A literature review

International Journal of COPD

Volumn 7, Issue , 2012, Pages 457-494

  Rycroft, Catherine E ^a   Heyes, Anne ^a   Lanza, Lee ^a   Becker, Karin ^b  

^a RTI HEALTH SOLUTIONS   (United States)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

COPD; Incidence; Literature review; Mortality; Prevalence

Indexed keywords

AGE DISTRIBUTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; LUNG FUNCTION TEST; MEDICAL LITERATURE; MORTALITY; PREVALENCE; REVIEW; SEX DIFFERENCE; SMOKING; SPIROMETRY; SYSTEMATIC REVIEW; TREND STUDY; ADOLESCENT; ADULT; AGED; AUSTRALIA; CHILD; EUROPE; FEMALE; MALE; MIDDLE AGED; NORTH AMERICA; RISK ASSESSMENT; RISK FACTOR; TIME;

ADOLESCENT; ADULT; AGED; AUSTRALIA; CHILD; EUROPE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NORTH AMERICA; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SMOKING; TIME FACTORS; YOUNG ADULT;

EID: 84871522568     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S32330     Document Type: Review

References (121)

1. Rabe KF, Hurd S, Anzueto A, et al; Global Initiative for Chronich Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6): 532-555.
2. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study. Lancet. 1997;349:1498-1504.
3. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264-269, W64.
4. Lindberg A, Jonsson AC, Rönmark E, Lundgren R, Larsson LG, Lundbäck B. Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD, and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits. Respiration. 2005;72(5):471-479.
5. Celli BR, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J. 2003;22(2): 268-273.
6. Hnizdo E, Glindmeyer HW, Petsonk EL, Enright P, Buist AS. Case definitions for chronic obstructive pulmonary disease. COPD. 2006; 3(2):95-100.
7. Vaz Fragoso CA, Concato J, McAvay G, et al. The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;181(5):446-451.
8. Lindberg A, Bjerg A, Rönmark E, Larsson LG, Lundbäck B. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking. Report from the obstructive lung disease in Northern Sweden studies. Respir Med. 2006;100(2):264-272.
9. Lundbäck B, Lindberg A, Lindstrom M, et al; Obstructive Lung Disease in Northern Sweden Studies. Not 15 but 50% of smokers develop COPD? - Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med. 2003;97(2):115-122.
10. Cerveri I, Accordini S, Verlato G, et al; European Community Respiratory Health Survey (ECRHS) Study Group. Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults. Eur Respir J. 2001;18(1):85-92.
11. Al-Hazmi M, Wooldrage K, Anthonisen NR, et al. Airflow obstruction in young adults in Canada. Can Respir J. 2007;14(4):221-217.
12. Viegi G, Matteelli G, Angino A, et al. The proportional Venn diagram of obstructive lung disease in the Italian general population. Chest. 2004;126(4):1093-1101.
13. Celli BR, Halbert RJ, Nordyke RJ, Schau B. Airway obstruction in never smokers: results from the third national health and nutrition examination survey. Am J Med. 2005;118(12):1364-1372.
14. Hnizdo E, Sullivan PA, Bang KM, Wagner G. Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the third national health and nutrition examination survey. Am J Epidemiol. 2002;156(8): 738-746.
15. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance: United States, 1971-2000. MMWR Surveill Summ. 2002;51(6):1-16.
16. Methvin JN, Mannino DM, Casey BR. COPD prevalence in southeastern Kentucky: the burden of lung disease study. Chest. 2009;135(1): 102-107.
17. de Marco R, Accordini S, Cerveri I, et al. Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J Respir Crit Care Med. 2007;175(1):32-39.
18. Gershon AS, Wang C, Wilton AS, Raut R, To T. Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in Ontario, Canada, 1996 to 2007: a population-based study. Arch Intern Med. 2010;170(6):560-565.
19. Kojima S, Sakakibara H, Motani S, et al. Incidence of chronic obstructive pulmonary disease, and the relationship between age and smoking in a Japanese population. J Epidemiol. 2007;17(2): 54-60.
20. Lindberg A, Jonsson AC, Rönmark E, Lundgren R, Larsson LG, Lundbäck B. Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. Chest. 2005;127(5): 1544-1552.
21. García Rodríguez LA, Wallander MA, Tolosa LB, Johansson S. Chronic obstructive pulmonary disease in UK primary care: incidence and risk factors. COPD. 2009;6(5):369-379.
22. Tan WC, Seale P, Ip M, et al. Trends in COPD mortality and hospitalizations in countries and regions of Asia-Pacific. Respirology. 2009;14(1):90-97.
23. Lindgren B. Trends in obstructive lung disease in hospital registers in Sweden 1987-1996. Eur Respir Rev. 2000;10(75):423.
24. Lipton R, Banerjee A. The geography of chronic obstructive pulmonary disease across time: California in 1993 and 1999. Int J Med Sci. 2007; 4(4):179-189.
25. Kabir Z, Connolly GN, Koh HK, Clancy L. Chronic obstructive pulmonary disease hospitalization rates in Massachusetts: a trend analysis. QJM. 2010;103(3):163-168.
26. Lindberg A, Eriksson B, Larsson LG, Rönmark E, Sandstrom T, Lundbäck B. Seven-year cumulative incidence of COPD in an age-stratified general population sample. Chest. 2006;129(4):879-885.
27. Camp PG, Chaudhry M, Platt H, et al. The sex factor: epidemiology and management of chronic obstructive pulmonary disease in British Columbia. Can Respir J. 2008;15(8):417-422.
28. Nie JX, Wang L, Upshur RE. Mortality of elderly patients in Ontario after hospital admission for chronic obstructive pulmonary disease. Can Respir J. 2007;14(8):485-489.
29. Lindberg A, Lundbäck B. The Obstructive Lung Disease in Northern Sweden Chronic Obstructive Pulmonary Disease Study: design, the first year participation and mortality. Clin Respir J. 2008;2(Suppl 1): 64-71.
30. Janssen F, Kunst AE. Cohort patterns in mortality trends among the elderly in seven European countries, 1950-1999. Int J Epidemiol. 2005; 34(5):1149-1159.
31. Wilson DH, Tucker G, Frith P, Appleton S, Ruffin RE, Adams RJ. Trends in hospital admissions and mortality from asthma and chronic obstructive pulmonary disease in Australia, 1993-2003. Med J Aust. 2007;186(8):408-411.
32. Janssen F, Nusselder WJ, Looman CW, Mackenbach JP, Kunst AE. Stagnation in mortality decline among elders in The Netherlands. Gerontologist. 2003;43(5):722-734.
33. Hansell AL, Walk JA, Soriano JB. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J. 2003;22(5):809-814.
34. Berend N. Epidemiological survey of chronic obstructive pulmonary disease and alpha-1-antitrypsin deficiency in Australia. Respirology. 2001;(Suppl 6):S21-S25.
35. Fuhrman C, Jougla E, Nicolau J, Eilstein D, Delmas MC. Deaths from chronic obstructive pulmonary disease in France, 1979-2002: a multiple cause analysis. Thorax. 2006;61(11):930-934.
36. Day GE, Lanier AP. Alaska native mortality, 1979-1998. Public Health Rep. 2003;118(6):518-530.
37. Day GE, Provost E, Lanier AP. Alaska native mortality rates and trends. Public Health Rep. 2009;124(1):54-64.
38. Edwards NM, Umland M, Ahrens D, Remington P. The silent epidemic among Wisconsin women: chronic obstructive pulmonary disease trends, 1980-2000. WMJ. 2005;104(4):50-54.
39. Hughes TS, Muldoon SB, Tollerud DJ. Underestimation of mortality due to chronic obstructive pulmonary disease (COPD) in Kentucky. J Ky Med Assoc. 2006;104(8):331-339.
40. Kazerouni N, Alverson CJ, Redd SC, Mott JA, Mannino DM. Sex differences in COPD and lung cancer mortality trends: United States, 1968-1999. J Womens Health. (Larchmt). 2004;13(1):17-23.
41. Lewis DR, Clegg LX, Johnson NJ. Lung disease mortality in the United States: the national longitudinal mortality study. Int J Tuberc Lung Dis. 2009;13(8):1008-1014.
42. Miller N, Simoes EJ, Chang JC, Robling AG. Trends in chronic obstructive pulmonary disease mortality. Mo Med. 2000;97(3):87-90.
43. Centers for Disease Control and Prevention (CDC). Deaths from chronic obstructive pulmonary disease: United States, 2000-2005. MMWR Morb Mortal Wkly Rep. 2008;57(45):1229-1232.
44. Rubia M, Marcos I, Muennig PA. Increased risk of heart disease and stroke among foreign-born females residing in the United States. Am J Prev Med. 2002;22(1):30-35.
45. Singh GK, Hiatt RA. Trends and disparities in socioeconomic and behavioural characteristics, life expectancy, and cause-specific mortality of native-born and foreign-born populations in the United States, 1979-2003. Int J Epidemiol. 2006;35(4):903-919.
46. Ezzati M, Lopez AD. Regional, disease specific patterns of smoking-attributable mortality in 2000. Tob Control. 2004;13(4):388-395.
47. Centers for Disease Control and Prevention (CDC). Smoking-attributable mortality, years of potential life lost, and productivity losses: United States, 2000-2004. MMWR Morb Mortal Wkly Rep. 2008;57(45): 1226-1228.
48. Ezzati M, Lopez AD. Estimates of global mortality attributable to smoking in 2000. Lancet. 2003;362(9387):847-852.
49. Henley SJ, Connell CJ, Richter P, et al. Tobacco-related disease mortality among men who switched from cigarettes to spit tobacco. Tob Control. 2007;16(1):22-28.
50. Atsou K, Chouaid C, Hejblum G. Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review. BMC Med. 2011;9:7.
51. Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest. 2003; 123(5):1684-1692.
52. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28(3):523-532.
53. Ko FW, Hui DS, Lai CK. Worldwide burden of COPD in high-and low-income countries, Part III. Asia-Pacific studies. Int J Tuberc Lung Dis. 2008;12(7):713-717.
54. Hurd S. The impact of COPD on lung health worldwide: epidemiology and incidence. Chest. 2000;117(Suppl 2):1S-4S.
55. OECD.StatExtracts [homepage on the Internet]. Organisation for Economic Co-operation and Development; 2011. Non-medical determinants of health: tobacco consumption. Available from: http://stats.oecd.org/index.aspx. Accessed July 13, 2011.
56. Foreman MG, Zhang L, Murphy J, et al. The COPDGene investigators. Early-onset COPD is associated with female gender, maternal factors, and African-American race in the COPDGene study. Am J Respir Crit Care Med. 2011;184(4):414-420.
57. Sheel AW, Guenette JA. Mechanics of breathing during exercise in men and women: sex versus body size differences? Exerc Sport Sci Rev. 2008;36(3):128-134.
58. Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J. 1997;10(4):822-827.
59. Langhammer A, Johnsen R, Gulsvik A, Holmen TL, Bjermer L. Sex differences in lung vulnerability to tobacco smoking. Eur Respir J. 2003;21(6):1017-1823.
60. Guenette JA, Jensen D, Webb KA, Ofir D, Raghavan N, O'Donnell DE. Sex differences in exertional dyspnea in patients with mild COPD: physiological mechanisms. Respir Physiol Neurobiol. 2011;177(3): 218-227.
61. Thomas DP, Condon JR, Anderson IP, et al. Long-term trends in indigenous deaths from chronic diseases in the Northern Territory: a foot on the brake, a foot on the accelerator. Med J Aust. 2006;185(3): 145-149.
62. Bischoff EW, Schermer TR, Bor H, Brown P, van Weel C, van den Bosch WJ. Trends in COPD prevalence and exacerbation rates in Dutch primary care. Br J Gen Pract. 2009;59(569):927-933.
63. Cricelli C, Mazzaglia G, Samani F, et al. Prevalence estimates for chronic diseases in Italy: exploring the differences between self-report and primary care databases. J Public Health Med. 2003;25(3):254-257.
64. Montnémery R, Nihlen U, Andersson M, et al. Obstructive airways diseases, smoking, and use of inhaled corticosteroids in southern Sweden in 1992 and 2000. Int J Tuberc Lung Dis. 2006;10(5):490-498.
65. Shahab L, Jarvis MJ, Britton J, West R. Prevalence, diagnosis, and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax. 2006;61(12): 1043-1047.
66. Soriano JB, Davis KJ, Coleman B, Visick G, Mannino D, Pride NB. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest. 2003;124(2):474-481.
67. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the national health and nutrition examination survey, 1988-1994. Arch Intern Med. 2000;160(11):1683-1689.
68. American Thoracic Society. Evaluation of impairment/disability secondary to respiratory disorders. Am Rev Respir Dis. 1986;133: 1205-1209.
69. Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J. Aug 1995;8(8): 1398-1420.
70. Nihlen U, Nyberg P, Montnémery P, Lofdahl CG. Influence of family history and smoking habits on the incidence of self-reported physician's diagnosis of COPD. Respir Med. 2004;98(3):263-270.
71. Soriano JB, Maier WC, Egger P, et al. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax. 2000;55(9): 789-794.
72. Stewart P, McRae L. Keeping track of COPD in Canada. Can Respir J. 2007;14(Suppl A):5A-7A.
73. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA. 2005;294(10):1255-1259.
74. Polednak AP. Trends in mortality from COPD in selected US states differing in tobacco control efforts. COPD. 2010;7(1):63-69.
75. Boutin-Forzano S, Moreau D, Kalaboka S, et al. Reported prevalence and co-morbidity of asthma, chronic bronchitis and emphysema: A pan-European estimation. Int J Tuberc Lung Dis. 2007;11(6):695-702.
76. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741-750.
77. Menotti A, Mulder I, Nissinen A, Giampaoli S, Feskens EJ, Kromhout D. Prevalence of morbidity and multimorbidity in elderly male popula-tions and their impact on 10-year all-cause mortality: The FINE study (Finland, Italy, Netherlands, Elderly). J Clin Epidemiol. 2001;54(7):680-686.
78. Rennard S, Decramer M, Calverley PM, et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of Con-fronting COPD International Survey. Eur Respir J. 2002;20(4): 799-805.
79. Svanes C, Omenaas E, Jarvis D, Chinn S, Gulsvik A, Burney P. Paren-tal smoking in childhood and adult obstructive lung disease: Results from the European Community Respiratory Health Survey. Thorax. 2004;59(4):295-302.
80. de Marco R, Accordini S, Cerveri I, et al; European Community Respiratory Health Survey Study Group. An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax. 2004;59(2):120-125.
81. Lacasse Y, Montori VM, Lanthier C, Maltis F. The validity of diagnos-ing chronic obstructive pulmonary disease from a large administrative database. Can Respir J. 2005;12(5):251-256.
82. Ohinmaa A, Schopflocher D, Jacobs P, et al. A population-based analysis of health behaviours, chronic diseases and associated costs. Chronic Dis Can. 2006;27(1):17-24.
83. Stewart P, McRae L. Keeping track of COPD in Canada. Can Respir J. 2007;14(Suppl A):5A-7A.
84. Chen Y, Breithaupt K, Muhajarine N. Occurrence of chronic obstruc-tive pulmonary disease among Canadians and sex-related risk factors. J Clin Epidemiol. 2000;53(7):755-761.
85. Hill K, Goldstein RS, Guyatt GH, et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ. 2010;182(7):673-678.
86. Vozoris N, Lougheed MD. Second-hand smoke exposure in Canada: prevalence, risk factors, and association with respiratory and cardio-vascular diseases. Can Respir J. 2008;15(5):263-269.
87. Huchon GJ, Vergnenegre A, Neukirch F, Brami G, Roche N, Preux PM. Chronic bronchitis among French adults: high prevalence and underdiagnosis. Eur Respir J. 2002;20(4):806-812.
88. Anecchino C, Rossi E, Fanizza C, De Rossi M, Tognoni G, Romero M; working group ARNO project. Prevalence of chronic obstructive pulmonary disease and pattern of comorbidities in a general popula-tion. Int J Chron Obstruct Pulmon Dis. 2007;2(4):567-574.
89. Fukahori S, Matsuse H, Takamura N, et al. Prevalence of chronic obstructive pulmonary diseases in general clinics in terms of FEV1/FVC. Int J Clin Pract. 2009;63(2):269-274.
90. Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: the Nip-pon COPD Epidemiology study. Respirology. 2004;9(4):458-465.
91. Kojima S, Sakakibara H, Motani S, et al. Effects of smoking and age on chronic obstructive pulmonary disease in Japan. J Epidemiol. 2005;15(4):113-117.
92. Tatsumi K. Epidemiological survey of chronic obstructive pulmonary disease in Japan. Respirology. 2001;(6 Suppl):S27-S33.
93. Miravitlles M, de la Roza C, Morera J, et al. Chronic respiratory symp-toms, spirometry and knowledge of COPD among general population. Respir Med. 2006;100(11):1973-1980.
94. Miravitlles M, Soriano JB, García-Río F, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009;64(10):863-868.
95. Peña VS, Miravitlles M, Gabriel R, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBER-POC multicentre epidemiological study. Chest. 2000;118(4): 981-989.
96. de Torres JP, Campo A, Casanova C, Aguirre-Jaime A, Zulueta J. Gen-der and chronic obstructive pulmonary disease in high-risk smokers. Respiration. 2006;73(3):306-310.
97. Ekberg-Aronsson M, Lofdahl K, Nilsson JA, Lofdahl CG, Nilsson PM. Hospital admission rates among men and women with symptoms of chronic bronchitis and airflow limitation corresponding to the GOLD stages of chronic obstructive pulmonary disease--a population-based study. Respir Med. 2008;102(1):109-120.
98. Hasselgren M, Arne M, Lindahl A, Janson S, Lundbäck B. Estimated prevalences of respiratory symptoms, asthma and chronic obstructive pulmonary disease related to detection rate in primary health care. Scand J Prim Health Care. 2001;19(1):54-57.
99. Lindstrom M, Jonsson E, Larsson K, Lundbäck B. Underdiagnosis of chronic obstructive pulmonary disease in Northern Sweden. Int J Tuberc Lung Dis. 2002;6(1):76-84.
100. Montnémery P, Bengtsson P, Elliot A, Lindholm LH, Nyberg P, Lofdahl CG. Prevalence of obstructive lung diseases and respiratory symptoms in relation to living environment and socio-economic group. Respir Med. 2001;95(9):744-752.
101. Pallasaho P, Lundbäck B, Meren M, et al. Prevalence and risk factors for asthma and chronic bronchitis in the capitals Helsinki, Stockholm, and Tallinn. Respir Med. 2002;96(10):759-769.
102. Rönmark EP, Ekerljung L, Lötvall J, Torén K, Rönmark E, Lun-dbäck B. Large scale questionnaire survey on respiratory health in Sweden: Effects of late-and non-response. Respir Med. 2009;103(12):1807-1815.
103. Wiréhen AB, Karlsson HM, Carstensen JM. Estimating disease preva-lence using a population-based administrative healthcare database. Scand J Public Health. 2007;35(4):424-431.
104. Faulconer ER, de Lusignan S. An eight-step method for assessing diagnostic data quality in practice: chronic obstructive pulmonary disease as an exemplar. Inform Prim Care. 2004;12(4):243-254.
105. Murtagh E, Heaney L, Gingles J, et al. Prevalence of obstructive lung disease in a general population sample: the NICECOPD study. Eur J Epidemiol. 2005;20(5):443-453.
106. Nacul LC, Soljak M, Meade T. Model for estimating the population prev-alence of chronic obstructive pulmonary disease: Cross sectional data from the health survey for England. Popul Health Metr. 2007;5:8.
107. Bang KM, Syamlal G, Mazurek JM. Prevalence of chronic obstruc-tive pulmonary disease in the U.S. working population: an analysis of data from the 1997-2004 National Health Interview Survey. COPD. 2009;6(5):380-387.
108. Bhattacharyya N. Contemporary assessment of the disease burden of sinusitis. Am J Rhinol Allergy. 2009;23(4):392-395.
109. Bhattacharyya N. Does annual temperature influence the preva-lence of otolaryngologic respiratory diseases? Laryngoscope. 2009;119(10):1882-1886.
110. Chamberlain AM, Schabath MB, Folsom AR. Associations of chronic obstructive pulmonary disease with all-cause mortality in Blacks and Whites: the atherosclerosis risk in communities (ARIC) study. Ethn Dis. 2009;19(3):308-314.
111. Hnizdo E, Sullivan PA, Bang KM, Wagner G. Airflow obstruc-tion attributable to work in industry and occupation among U.S. race/ethnic groups: a study of NHANES III data. Am J Ind Med. 2004;46(2):126-135.
112. Jackson H, Hubbard R. Detecting chronic obstructive pulmonary disease using peak flow rate: Cross sectional survey. Br Med J. 2003;327(7416):653-654.
113. Jordan JG Jr, Mann JR. Obesity and mortality in persons with obstruc-tive lung disease using data from the NHANES III. South Med J. 2010;103(4):323-330.
114. Lipton R, Banerjee A, Dowling KC, Treno AJ. The geography of COPD hospitalization in California. COPD. 2005;2(4):435-444.
115. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung func-tion and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax. 2003;58(5):388-393.
116. O'Malley AS, Pham HH, Schrag D, Wu B, Bach PB. Potentially avoid-able hospitalizations for COPD and pneumonia: the role of physician and practice characteristics. Med Care. 2007;45(6):562-570.
117. Pleis JR, Barnes PM. A comparison of respiratory conditions between multiple race adults and their single race counterparts: An analysis based on American Indian/Alaska Native and white adults. Ethn Health. 2008;13(5):399-415.
118. Schneider KM, O'Donnell BE, Dean D. Prevalence of multiple chronic conditions in the United States' Medicare population. Health Qual Life Outcomes. 2009;7:82.
119. Tinkelman DG, George D, Halbert RJ. Chronic obstructive pulmonary disease in patients under age 65: Utilization and costs from a managed care sample. J Occup Environ Med. 2005;47(11):1125-1130.
120. Wilson L, Devine EB, So K. Direct medical costs of chronic obstruc-tive pulmonary disease: chronic bronchitis and emphysema. Respir Med. 2000;94(3):204-213.
121. Ohar JA, Sadeghnejad A, Meyers DA, Donohue JF, Bleecker ER. Do symptoms predict COPD in smokers? Chest. 2010;137(6):1345-1353.